EPO Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Recombinant erythropoietin (EPO) is currently indicated for use only in anemia associated
with renal transplant or end-stage renal disease. Widened indications for use in other
forms of anemia, accompanied by price reductions as a result of keen competition, have
been projected for EPO in the future.
Originator
Amgen (USA)
Trademarks
Eprex
EPO Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte